Simvastatin enhances endothelial differentiation of peripheral blood mononuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes

Clinica Chimica Acta

Volumn 388, Issue 1-2, 2008, Pages 156-166

  Park, Kyung Woo ^a,b   Hwang, Kyung Kuk ^c   Cho, Hyun Ju ^a   Hur, Jin ^a   Yang, Han Mo ^a,b   Yoon, Chang Hwan ^a   Kang, Hyun Jae ^a,b   Oh, Byung Hee ^a,b   Park, Young Bae ^a,b   Kim, Hyo Soo ^a,b  

^a National Research Laboratory for Molecular Cell Imaging   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Chungbuk National University Hospital   (South Korea)

Author keywords

Cytokines; Endothelial progenitor cells; HMG CoA reductase inhibitors; Hypercholesterolemia; Interleukin 8

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE ACETYLATED LOW DENSITY LIPOPROTEIN; INTERLEUKIN 8; LIPOPROTEIN; SIMVASTATIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BLOOD; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYO; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; HYPERCHOLESTEROLEMIA; INTERLEUKIN-8; MICE; MONOCYTES; SIMVASTATIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 37249011905     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.10.027     Document Type: Article

References (45)

1. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 participants with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet 344 (1994) 1383-1389
2. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol concentrations. N Engl J Med 335 (1996) 1001-1009
3. Koh K.K. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res 47 (2000) 648-657
4. Sposito A.C., and Chapman M.J. Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit. Arterioscler Thromb Vasc Biol 22 10 (2002) 1524-1534
5. Porter K.E., Naik J., Turner N.A., Dickinson T., Thompson M.M., and London N.J. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth smucle cell proliferation and migration. J Vasc Surg 36 1 (2002) 150-157
6. Kohno M., Shinomiya K., Abe S., et al. Inhibition of migration and proliferation of rat vascular smooth muscle cells by a new HMG-CoA reductase inhibitor, pitavastatin. Hypertens Res 25 2 (2002) 279-285
7. Hristov M., Erl W., and Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23 (2003) 1185-1189
8. Assmus B., Schachinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
9. Tateishi-Yuyama E., Matsubara H., Murohara T., et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation bone marrow cells: a pilot study and a randomized controlled trial. Lancet 360 (2002) 427-435
10. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 9411 (2004) 751-756
11. Kang H.J., Lee H.Y., Na S.H., et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation 114 1 Suppl (2006) I145-I151
12. Urbich C., and Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 67 5 (2005) 1672-1676
13. Chen J.Z., Zhang F.R., Tao Q.M., Wang X.X., Zhu J.H., and Zhu J.H. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 107 3 (2004) 273-280
14. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow derived endothelial progenitor cells. J Clin Invest 108 (2001) 399-405
15. Dimmeler S., Aicher A., Vasa M., et al. HMG-co A reducatse inhibitors (statins) increase endothelial progenitor cells via the PI3-kinese/ Akt pathway. J Clin Invest 108 (2001) 391-397
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. Yoon C.H., Hur J., Park K.W., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112 11 (2005) 1618-1627
18. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
19. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., and Yamada K.M. Inhibition of cell migration, spreading and focal adhesions by tumor suppressor PTEN. Science 280 (1998) 1614-1617
20. Asahara T., Takahashi T., Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 14 (1999) 3964-3972
21. Kalka C., Masuda H., Takahashi T., et al. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 12 (2000) 1198-1202
22. Koch A.E., Polverini P.J., Kunkel S.L., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1999) 1798-1801
23. Hur J., Yoon C.H., Kim H.S., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24 2 (2004) 288-293
24. Vasa M., Fichtlscherer S., Sdler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
25. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 22 (2005) 2981-2987
26. Kureishi Y., Luo Z., Shiojima I., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6 9 (2000) 1004-1010
27. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendotherlialization. Circulation 105 (2002) 3017-3024
28. Vincent L., Soria C., Mirshahi F., et al. Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in vivo models. Arterioscler Thromb Vasc Biol 22 (2002) 623-629
29. Park H.J., Kong D., Iruela-Arispe L., Begley U., Tang D., and Galper J.B. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 91 2 (2002) 143-150
30. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., and Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109 3 (2002) 337-346
31. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 3 (2000) 952-958
32. Cortes F., Debacker C., Peault B., and Labastie M.C. Differential expression of KDR/VEGFR-2 and CD34 during mesoderm development of the early human embryo. Mech Dev 83 1-2 (1999) 161-164
33. Rafii S., Oz M.C., Seldomridge J.A., et al. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg 60 6 (1995) 1627-1632
34. Solovey A., Lin Y., Browne P., Choong S., Wayner E., and Hebbel R.P. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337 (1997) 1584-1590
35. Hu D.E., Hori Y., and Fan T.P. Interleukin-8 stimulates angiogenesis in rats. Inflammation 17 (1993) 135-143
36. Fibbe W.E., Pruijt J.F., van Kooyk Y., Figdor C.G., Opdenakker G., and Willemze R. The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization. Semin Hematol 37 (2000) 19-24
37. Watanabe T., Kawano Y., Kanamaru S., et al. Endogenous interleukin-8 surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Blood 93 4 (1999) 1157-1163
38. Rezaie-Majd A., Maca T., Bucek R.A., et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 22 7 (2002) 1194-1199
39. Kiener P.A., Davis P.M., Murray J.L., Youssef S., Rankin B.M., and Kowala M. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors. Int Immunopharmacol 1 (2001) 105-118
40. Skaletz-Rorowski A., Kureishi Y., Shiojima I., and Walsh K. The pro- and antiangiogenic effects of statins. Semin Vasc Med 4 4 (2004) 395-400
41. Weis M., Heeschen C., Glassford A.J., and Cooke J.P. Statins have biphasic effects on angiogenesis. Circulation 105 6 (2002) 739-745
42. Urbich C., Dernbach E., Zeiher A.M., and Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 90 (2002) 737-744
43. Hristov M., Fach C., Becker C., et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 192 2 (Jun 2007) 413-420
44. Shiojima I., and Walsh K. Role of Akt signaling invascular homeostasis and angiogenesis. Circ Res 90 (2002) 1243-1250
45. Levy L., Neuveut C., Renard C.A., et al. Transcriptional activation of IL-8 by beta-catenin-Tcf 4. J Biol Chem 277 44 (2002) 42386-42393